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The high heterogeneity of native rat liver EF-2 prepared from either 105000 x g supernatant or microsome high-salt 
extract was detected by two-dimensional equilibrium isoelectric focusing-SDS-polyacrylamide gel lectrophoresis in the 
presence of 9.5 M urea. Five spots were always detected, all of Mr 95000, which were not artefactual for their amount 
varied when EF-2 was specifically ADP-ribosylatecl by diphtheria toxin in the presence of NAD +, and/or phosphorylated 
on a threonine residue by a Ca2+/calmodulin-dependent protein kinase (most likely Ca2+/calmodulin-dependent protein 
kinase III described by others [(1987) J. Biol. Chem. 262, 17299--17303; 988) Nature 334, 170-173]). Results of ADP- 
ribosylation and/or phosphorylation experiments with either unlabeled or labeled reagents ([14C]NAD and p2p]ATP) 
strongly suggest that our preparation contained native ADP-ribosylated and native phosphorylated forms which could 
be estimated at about 20% and 40% of the whole EF-2. Phosphorylated and ADP-ribosylated forms of EF-2 could be 
ADP-ribosylated and phosphorylated, respectively, but a native form both ADP-ribosylated and phosphorylated was 
not detected. Our results also suggest the existence of a minor native form of EF-2 and of its phosphorylated and ADP- 
ribosylated derivatives. 
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1. INTRODUCTION 
Elongation factor 2 (EF-2), a single polypeptide 
of 857 amino acids (95 kDa), catalyzes the last step 
of the elongation cycle, translocation, i  the course 
of protein biosynthesis. EF-2 is the only known 
protein which has the feature of being ADP- 
ribosylated and inactivated by diphtheria toxin in 
the presence of NAD +. ADP-ribosylation occurs at 
a unique post-translationally modified histidine 
residue (diphtamide 715) only found in EF-2 and 
conserved throughout eukaryotic evolution (see 
[3]). Diphtamide 715 whose importance for the 
function of EF-2 has recently been stressed [4] is 
most likely a site of regulatory modifications of the 
factor because an ADP-ribosyltransferase, with the 
same mechanism of action as diphtheria toxin, and 
its inhibitor has been recently identified in different 
cells [5,6]. However, identification of an in vivo 
ADP-ribosylated EF-2 has only been done in 
polyoma-virus-transformed baby hamster kidney 
cells, very recently [7]. On the other hand, phos- 
phorylation of a maximum of 2 threonine residues, 
one that lies between residues 51-60 of rat pancreas 
EF-2, specifically by the Ca2+/calmodulin - 
dependent protein kinase III, has been shown to in- 
activate the factor, while dephosphorylation 
restored its activity [1,2]. Whether a relation exists 
between phosphorylation a d ADP-ribosylation is 
still unknown. In the present paper, we attempted 
to identify the 5 different forms of rat liver EF-2 
that we were able to separate using an O'Farrell 
two-dimensional electrophoretic system [8]. 
2. MATERIALS AND METHODS 
Correspondence address: A. Marzouki, Laboratoire de Bio- 
chimie M6dicale, Universit6 Lyon I, UM CNRS 24, 43, Boule- 
vard du 11 Novembre 1918, 69622 Villeurbanne, France 
2.1. Materials 
Pure diphtheria toxin was a gift from Professor Relyveld 
(Pasteur Institute, Paris); nicotinamide [t4C]adenine di- 
nucleotide ([14ClNAD+, 10.5 GBq/mmol) and [7-3zP]ATP 
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(ll0 TBq/mmol) were purchased from Amersham; NAD + and 
ATP from Sigma. 
staining and counting of the labeled spots, not suitable for the 
slightly stained (labeled) spots. 
2.2. Preparations 
EF-2 (95°70 pure) was prepared from a ratliver microsome 
high-salt extract according to [9], or from rat liver supernatant 
by a method adapted from the preceding one, with the same 
basic purification steps. Such preparations incorporated from 
0.6 to 0.8 mol of [14C]ADP-ribose p r mol of EF-2, in the 
presence of diphtheria toxin. 
2.3. Phosphorylation and~or ADP-ribosylation of EF-2 
EF-2 (90 pmol) was incubated as indicated in the legend of 
table 1. Both reactions were performed in 50/A of buffer A 
(20 mM triethanolamine, pH 7.4, 8 mM acetate, 150/zM CaC12, 
100 mM KC1, 1 mM dithiothreitol, 100 mM sucrose). In the 
phosphorylation assays 2/~g of rat liver cytosoi [1] and 10 nmol 
of ATP (with or without 1.53 pmol of [7-32p]ATP) were used. 
In the ADP-ribosylation assays, 3.4 #g of diphtheria toxin, 
434 pmol of NAD + or [14C]NAD+ were used. Control ex- 
periments performed by incubating the factor with [7-32p]ATP, 
diphtheria toxin, [~4C]NAD separately, showed neither labeling 
of the factor nor modifications of its electrophoretic pattern 
compared with that of EF-2 incubated alone in buffer A for the 
duration of the reactions. Other control experiments have 
shown that free EF-2 could not be phosphorylated in the 
presence of EGTA (1 mM) or trifluoperazine (200/~M) in- 
dicating that the kinase was Ca2+/calmodulin (CaM)- 
dependent, most likely CaM kinase III described by others [1,2]. 
2.4. 2-D electrophoresis 
Two-dimensional gel analysis in an equilibrium pH gradient- 
SDS system in the presence of 9.5 M urea was performed accor- 
ding to O'Farrell [8]. All samples were analyzed at the same time 
under identical electrophoretic conditions. Different pH gra- 
dients in the first dimension have been used as indicated in the 
text. The gels stained with Coomassie blue were auto- 
radiographed with different exposure times. Both gels and auto- 
radiograms were photographed with the same magnification. 
Every EF-2 spot was identified on the stained gel by its position 
relative to those of two slightly stained proteins always present 
in our preparation and never phosphorylated nor ADP- 
ribosylated (X of Mr 62 500, pHi around 7.1 and Y of Mr 43 000, 
pHi around 7.5) and by its pHi determined according to [8]. 
Other proteins used as internal controls, such as diphtheria tox- 
in subunits A and B present in ADP-ribosylation experiments, 
were repeatedly found to have the same relative position and 
pHi value from one experiment to another, which confirmed 
that there was no ambiguity in the matching of any EF-2 spot 
from one experiment toanother. The specific radioactivity (SR) 
of each spot was determined by direct scanning of photographs 
using a Vernon photometer and expressed by the ratio of 
darkness of the labeled spot ([t4C] or [32P]):darkness of th  
stained spot. Each setof photographs of the [32p] and [14C] 
autoradiograms and of the stained gels wa  scanned under iden- 
tical conditions which differed from one set t  the other because 
of the large variations f the darkness of the spots in the dif- 
ferent sets. This means that he SR values can be compared only 
within experiments using the same isotope. This method of SR 
quantification was preferred to that of direct determination of 
3. RESULTS AND DISCUSSION 
Native EF-2 subjected to O'Farrel l  two- 
dimensional  separation in the presence of 9.5 M 
urea always showed 5 spots, all of Mr 95 000 and of 
pHi values varying from about 7.3 to 7.7 (These 
pHi values are relative, since high concentrations 
of urea cause large changes in pHi of proteins [8].): 
two trail ing ones, one near the cathode nd (a) and 
another more acidic (b), and three well resolved 
spots (c-e) (fig. l, expt 5). These spots were observ- 
ed whatever the pH gradient used in the first 
dimension: pH 5-8, as shown in f ig. l ,  or pH 4-9 
(not shown). In the latter case, the spot correspon- 
ding to (a) was more intense but the other spots 
were less well resolved. An  artefactual heterogenei- 
ty of EF-2 could be discarded for two reasons: 
these forms were found within all EF-2 prepara- 
t ions examined (5 derived from the 105 000 x g 
supernatant and 3 from microsome high-salt ex- 
tract); their amount  varied when the factor 
preparat ion was submitted to specific reactions of 
ADP-r ibosylat ion and/or  phosphorylat ion, which 
suggested that some of the EF-2 forms found ' in 
vivo' were ADP-r ibosylated and/or  phos- 
phorylated. 
In order to characterize every native EF-2 form, 
EF-2 was submitted to ADP-r ibosylat ion and/or  
phosphorylat ion with either labeled or unlabeled 
reagents as indicated in table 1 (column 2), then the 
factor submitted to O'FarreU two-dimensional gel 
electrophoresis and every native EF-2 form was 
identified with regard to the labeled ones. The 
stained electrophoretograms and their correspon- 
ding autoradiograms are shown in fig.1 and the 
results of these summarized in table 1. As indicated 
in section 2 there was no possibility of mismatching 
any EF-2 spot from one experiment to another. 
Results of experiments 1-4, repeated 5 times, 
showed that of the spots (a-e) seen in native EF-2, 
c and e (or at least part of them) subsisted to all 
reactions while a, b and d disappeared after ADP-  
r ibosylat ion (expt 2) and a fortiori after ADP-  
r ibosylat ion + phosphorylat ion (expts 3,4). More- 
over, the spots (a-e) seen in native EF-2 (expt 5) 
could be characterized as follows: a was never 
ADP-r ibosylated nor phosphorylated and there- 
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Fig. 1. Two-dimensional equilibrium isoelectric focusing-SDS-polyacrylamide gel el ctrophoresis of EF-2 after phosphorylation nd/or 
ADP-ribosylation. EF-2 was submitted to [32p]phosphorylation (expt 1), [~4C]ADP-ribosylation (expt 2), phosphorylation + [~4C]- 
ADP-ribosylation (expt 3), and [32p]phosphorylation + ADP-ribosylation (expt 4) as indicated inthe legend oftable I and insection 
2 before being electrophoresed according to [8] in the presence of 9.5 M urea and using a pH 5-8 gradient. For the control i  expt 5, 
EF-2 was incubated in buffer A for 15 min at 37°C + 2 min at 30°C. Each gel stained with Coomassie blue (top of each set of 
photographs) was dried and autoradiographed 16 h at -70°C (bottom). 
fore represented unmodified EF-2; b and d were 
phosphorylated (expt 1); c was ADP-ribosylated 
(expt 2), which is a new finding; e was a mixture of 
two forms: one ADP-ribosylated (el) and one 
phosphorylated (e2). Indeed e was either ADP- 
ribosylated or phosphorylated during ADP- 
ribosylation or phosphorylation experiments (expts 
2,1), but only ADP-ribosylated and no longer 
phosphorylated after both ADP-ribosylation + 
phosphorylation (expts 3,4): the phosphorylated 
form (e2) seen in expt 1 had undergone ADP- 
ribosylation in expt 4 and had then migrated to a 
more acidic region with either f, g or h. These 3 
forms were labeled in both expt 3 and expt 4 and 
therefore were both ADP-ribosylated and phos- 
phorylated. None of these forms were detected in 
vivo even after repeated silver staining. The ap- 
pearance of f and g only after the phosphorylation 
reaction (expt 1) (g becoming clearly visible after a 
longer exposure) strengthened our conclusion that 
the EF-2 preparation contained in  vivo ADP- 
ribosylated forms and indicated that these were 
capable of being phosphorylated. Likewise the ap- 
pearance of f, g, h only after the ADP-ribosylation 
reaction (expt 2) (h becoming visible after a longer 
exposure) agreed with the existence of an endo- 
genously phosphorylated EF-2 and indicated that 
these were capable of being ADP-ribosylated. 
Since there is only one site (diphtamide 715) for 
ADP-ribosylation on the EF-2 molecule, the 
multiplicity of the EF-2 forms suggested that some 
forms could have more than one phosphorylation 
site, which would be in agreement with [2]. We 
found that the different forms of EF-2 were phos- 
phorylated on threonine only, in agreement with 
[1,2]" the same phosphopeptide was found after ex- 
tensive trypsinolysis of f and g, probably that se- 
quenced by Nairn and Palfrey [1], and a more 
acidic phosphopeptide was obtained from h treated 
under the same conditions (results not shown). In 
order to determine the degree of phosphorylation 
of each form, specific radioactivity (32p SR) of 
every spot was determined, as indicated in section 
2, and then compared to that of the other EF-2 
forms in expt 1 (after rapid 32p-phosphorylation: 
2 min at 30°C) and expt 4 (after extensive 32p_ 
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Table 1 
Comparison from ADP-ribosylation and/or phosphorylation f the different EF-2'spots i 
September 1989 
Expt Reactions il Characteristics i~ EF-2 spots iv
a b c d e 
el e2 
(I+II) (Ip) (IA) (Ilp) (IIA) (Ipp) 
f g h 
(IpA) (IIpA) (IppA) 
1 [32p]phosphoryl. SI 68* 54 18 13 
32p LI 0 90 0 27 
32p SR 0 1.7 0 2.1 
2 [14C]ADP-ribosyl. SI 0 0 66 0 41 
14C LI 0 0 65 0 38 
14C SR 1.0 0.9 
3 phosphoryl. + [14C]ADP- SI 0 0 31 0 20 
-ribosyl. 
14C LI 0 0 29 0 21 
t4C SR 0.9 1.0 
4 [32p]phosphoryl. SI 0 0 18 0 12 
+ ADP-ribosyl. 32p LI 0 0 0 0 0 
32p SR 0 0 
32p SR/14C SR 
(expt 3) 
9 
33 
3.7 
n.d° 
21 
1.9* 
10 
9 
0.9 
54 
8 
9 
1.1 
47 16 
82 66 23 
1.5 1.4 1.4 
46 28 5 
160 109 36 
3.5 3.9 7.2 
2.3 2.8 5.1 
iResults were from the two-dimensional electrophoregrams and utoradiograms seen in fig. 1 
ii Every sample was incubated under the conditions described in section 2, as follows: in expt 1, EF-2 was preincubated in buffer A for 
15 min at 37°C (the duration of the ADP-ribosylation assay) before being phosphorylated for 2 min at 30°C; in expt 2, EF-2 was prein- 
cubated for 2 min at 30°C (the duration of the phopshorylation assay) before being ADP-ribosylated for 15 min at 37°C; in expts 3 
and 4, EF-2 was both phosphorylated (2 min at 30°C) and ADP-ribosylated (15 min at 37°C) 
iii Staining intensity (SI) and 32p or ~4C labeling intensity (32p LI, 14C LI) were determined from direct scanning of the photographs 
seen in fig. 1. Specific radioactivity (32p SR or 14C SR) of every EF-2 spot was determined asindicated in section 2. 
iv Each EF-2 spot was indicated to be derived from either EF-2 1 or EF-2 II and to be ADP-ribosylated (A), monophosphorylated (p), 
biphosphorylated (pp) or both (pA or ppA) as indicated in the text 
* Mean of values obtained from two experiments identical to expt 1 and performed at the same time, during which: form a had 
penetrated into the first dimension gel (this was not the case in expt 1: there are often slight variations at the basic end of the isoelectric 
focusing els, see [8]) and the gel was more uniformly destained around f than in expt 1 
phosphorylation a d ADP-ribosylation: duration 
of phosphorylation, 2 min at 30°C; duration of 
ADP-ribosylation, 15 min at 37°C). In expt 4, the 
32p SR/~4C SR ratio was also determined using the 
14C SR values from the corresponding spots in expt 
3. Comparison of the SR values listed in table 1, 
allowed us to complete the characterization f the 
labeled EF-2 spots (expt 1) as follows: assuming 
that b and d were monophosphorylated, f was both 
monophosphorylated an ADP-ribosylated, e2 was 
biphosphorylated and its amount was larger than 
that of e~ (since the 32p SR value of e was about 
twice that of b, d and f which would not be the case 
if e2 was not largely predominant), d had a 32p SR 
value 24°7o higher than that of b for it was less 
diluted by endogenously phosphorylated EF-2 (cf. 
b and d in control expt 5, fig.l). That monophos- 
phorylated forms, b and d, had different pHi 
values indicating that they were probably derived 
from two slightly different EF-2 species (I and II). 
Comparison of 32p SR and 32p SR/14C SR values 
for the different spots in expts 4 and 3 allowed us 
to characterize completely the g and h spots, g as f 
was both monophosphorylated and ADP- 
ribosylated, and because their different pHi values, 
f and g are probably also derived from two dif- 
ferent EF-2 species, very likely the I and II species 
already discussed, h was both biphosphorylated 
and ADP-ribosylated. Indeed this form was 
characterized by32p SR and 32p SR/14 C SR values 
about wice those of f and g. That f and g had a 32p 
SR value in expt 4 about twice as high as that of f 
in expt 1 is an indication of a lower dilution by en- 
dogenously phosphorylated forms in expt 4 than in 
expt 1. Indeed the unmodified EF-2 (I + II) forms 
(a), transformable into the f, g, h ones, had been 
completely transformed in expt 4 but subsisted in a 
relatively high amount in expt 1 (see table 1). More- 
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over an analysis of the staining compared with the 
labeling intensities of every EF-2 spot, tentatively 
characterized as indicated in table 1 (3rd line), 
allowed us to deduce that f, g, h seen in expt 4 
derived from a through either b, d and e2, which 
totally disappeared from expt 1 to 4, or c and el, 
whose amount diminished from one half to two 
thirds when comparing expt 2 with expts 3 and 4, 
but never disappeared. This indicated that phos- 
phorylated forms: b, d and e2 were totally ADP- 
ribosylatable. The remaining ADP-ribosylated 
forms c and e~ seen in expt 4 might result from the 
action of phosphatase(s), present in the cytosol ex- 
tract used for phosphorylation, on part of f, g, h 
forms. The other possibility that ADP-ribosylated 
forms c and e~ were only partly phosphorylatable, 
although less likely, could not be totally discarded. 
Comparison of 14C SR values of EF-2 spots in 
expts 2 and 3 indicated that after extensive phos- 
phorylation (expt 3), f, g and h had an SR value 
slightly higher than c and el in expts 2 and 3 and 
higher than f and g in expt 2. This was most likely 
due to a lower dilution of the ~4C labeling by in 
vivo ADP-ribosylated factor in the first case com- 
pared with the other ones. In order to provide sup- 
plementary evidence that native EF-2 contained 
phosphorylated and ADP-ribosylated forms, the 
factor was treated with alkaline phosphatase or 
with diphtheria toxin a d nicotinamide under con- 
ditions of de-ADP-ribosylation [5]. Both 
treatments considerably decreased the solubility of 
the factor. Most of this did not penetrate into the 
gel and the remaining forms were poorly resolved. 
The amounts of native ADP-ribosylated and 
phosphorylated EF-2 forms could be estimated by 
comparing the staining intensity of the major 
forms c and b seen in native EF-2 (expt 5) to that 
of the total EF-2 forms, which was determined in
several experiments under different conditions. 
These estimations were about 20% and 40%, 
respectively. However, in the cell the amount of en- 
dogenous ADP-ribosylated EF-2 is probably 
higher than that estimated here becaue at each step 
of EF-2 purification we collected the fractions 
which were the most active in the [14C]ADP- 
ribosylation assay with diphtheria toxin. The 
amount of endogenous phosphorylated forms is 
probably also underestimated due to the action of 
phosphatases during the first step of EF-2 prepara- 
tion. The existence of native ADP-ribosylated EF-2 
could explain why, in all our experiments, EF-2 ac- 
cepted only 0.6 to 0.8 mol of ADP-ribose/mol. 
The fact that the relative amounts of several EF-2 
derivatives probably varied according to the state 
of the cell could also explain why during the 
purification steps EF-2 was eluted from ion- 
exchange columns under slightly different condi- 
tions from one experiment tothe other. The minor 
form (II) of native EF-2 could be estimated to 
represent less than 25% of total EF-2, from the 
ratio value of the staining intensity of g/staining in- 
tensity of whole EF-2 determined in expt 4 (dis- 
regarding el which should also be derived from 
EF-2 II). EF-2 II could be due to a proteolysis of 
native EF-2 near one nd of the molecule, which 
would not change its Mr significantly, or to the 
presence of bound GDP, which would resist elec- 
trophoresis and modify its pHi, or to differences in
the primary structure of the molecule. 
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